VivoSim Labs News

Latest VivoSim Labs Stock News & VIVS Headlines

VivoSim Labs and Chemveda Life Sciences Join Forces to Put AI-Designed Drug Candidates to the Human Test

12 days ago | globenewswire.com

VivoSim Labs Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker Profiling

25 days ago | globenewswire.com

VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods

a month ago | globenewswire.com

VivoSim Labs (NASDAQ:VIVS) vs. iSpecimen (NASDAQ:ISPC) Head to Head Comparison

2 months ago | defenseworld.net

VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs

2 months ago | globenewswire.com

VivoSim Labs to Add Rat Liver Model to NAMkind Platform

2 months ago | globenewswire.com

VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services

4 months ago | globenewswire.com

VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027

4 months ago | globenewswire.com

VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting

5 months ago | globenewswire.com

VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting

5 months ago | globenewswire.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

VIVS

VivoSim Labs

$ 0.1271

-7.83%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated a day ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

VivoSim Labs News

Latest VivoSim Labs Stock News & VIVS Headlines

Download App

People Also Watch

Explore our Tools